ArticleMedical oncology (Northwood, London, England)2008

Bleomycin, etoposide and cisplatin (BEP) combination with concurrent imatinib mesylate (GLEEVEC) in chronic myeloid leukemia (CML) patient with mesenchymal tumor.

Hasan Senol Coşkun et al.PubMed ↗Publisher ↗

No numbers read from the abstract.